Transforming Abu Dhabi into a Global Biotechnology Hub through Local Pharmaceutical Production

Transforming Abu Dhabi into a Global Biotechnology Hub



In a significant development for the healthcare landscape in the Middle East, the Department of Health – Abu Dhabi (DoH) has established a pioneering partnership with Abbott, a leader in global healthcare. This collaboration was formalized during the BIO International Convention held in Boston, USA, indicating a concerted effort to bolster the local pharmaceutical industry in Abu Dhabi.

A Step Towards Self-Sufficiency


The core of this partnership revolves around the localization of pharmaceutical manufacturing in Abu Dhabi. The emirate seeks to reduce its reliance on imported healthcare products, fostering a more resilient supply chain while promoting a sustainable and self-sufficient healthcare ecosystem. This move signifies a strategic shift towards enhancing the biopharmaceutical capabilities within the region.

Dr. Noura Al Ghaithi, Undersecretary of the Department of Health in Abu Dhabi, emphasized this commitment stating that the recent establishment of the Health, Endurance, Longevity, and Medicine (HELM) cluster is a testament to Abu Dhabi's robust infrastructure in supporting local production and research. This initiative aims to accelerate the development and deployment of innovative health products and solutions. It is designed to reduce time-to-market for groundbreaking therapies, ensuring that patients have quicker access to cutting-edge treatments.

Key Components of the Collaboration


The partnership with Abbott is based on a comprehensive strategy that targets four main pillars:
1. Localization of Abbott’s Pharmaceutical Portfolio: This initiative focuses on producing existing pharmaceutical products locally, thus supporting the emirate’s health sector.
2. Development of Biosimilars: By collaborating on biosimilars, the partnership aims to broaden the range of treatment options available to patients while also managing healthcare costs.
3. Digital Transformation: The duo will also work on implementing digital solutions, including electronic patient leaflets, which align with the UAE's digital health strategy.
4. Education and Workforce Development Initiatives: A strong emphasis is placed on developing local talent and building capacity within the healthcare sector.

Mazen Bachir, Abbott's Regional Director for its established pharmaceutical business in the Gulf region, highlighted the importance of this strategic partnership, stating that it will aim to enhance resilience and innovation in Abu Dhabi's healthcare sector. The cooperation will not only localize existing pharmaceutical products but also facilitate joint research into new biosimilars, supported by appropriate regulatory alignment.

A Focused Delegation


Leading this initiative, a high-level delegation from Abu Dhabi is undertaking a strategic mission in the United States from June 15 to 21, 2025. This mission includes over 20 strategic meetings with key public and private sector representatives, aimed at exchanging knowledge, exploring investment opportunities, and signing new agreements that will accelerate the introduction of advanced healthcare solutions.

The delegation represents a rich tapestry of Abu Dhabi's innovation ecosystem, including entities such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, Etihad Cargo, and distinguished educational institutions like NYU Abu Dhabi and Khalifa University.

Looking Ahead


This partnership represents a monumental step towards positioning Abu Dhabi as a regional leader in biopharmaceuticals, fostering an agile, innovative healthcare ecosystem. By aligning local production capabilities with strategic partnerships, Abu Dhabi aims to transform scientific advancements into tangible societal benefits, ultimately enhancing health outcomes for its residents and beyond. The collaboration with Abbott marks a pivotal moment, paving the way for future growth and sustainability in the biotechnology sector in the Arab world.

In conclusion, the synergy between the Department of Health – Abu Dhabi and Abbott is not just about manufacturing; it encapsulates a broader vision for healthcare innovation, making Abu Dhabi a healthcare powerhouse on the global stage.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.